VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System

Contributed by: Business Wire

Logo

Tags

Science

Cardiology

Other Science

Research

General Health

Health

Medical Devices

Clinical Trials

medical devices

More Like This

VDYNE Receives FDA Approval to Initiate the TRIVITA1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System

PR Newswire associated0

Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System

PR Newswire associated0

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

Business Wire embedded0

CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device

Business Wire embedded0

CroíValve Announces Funding from Horizon Europe EIC Accelerator

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study